KEARNEYSVILLE – Randox Laboratories, a leading international medical diagnostic company, opened its U.S. headquarters in Kearneysville Tuesday morning. Randox was founded by Dr. Peter FitzGerald in 1982 in the U.K., and the company now has offices on six continents. “This is obviously a great day for us,” said Tom Bayuzik, executive director of the Jefferson [...]

News reports cover developments in the pharmaceutical and medical device industries. The Associated Press: “Makers of X-ray machines, drug pumps and other medical devices would have to submit more safety information to win federal approval under a proposal designed to tighten regulation of thousands of products reviewed each year. The Food and Drug Administration released [...]

Researchers speaking at an annual conference suggested that research into making an artificial pancreas so patients with type 1 diabetes can better control glucose levels, is progressing rapidly and that the technology could be commercially available in just a few years. On Sunday, as part of the 70th Scientific Sessions of the American Diabetes Association [...]

anaries…bones…what’s next? Now that we are no longer “green” about the environment, there is increased motivation to advance the science of biomarkers as related to detecting chemical pollutants. Researchers from the U.S. and Russia are now announcing that samples of human bone can act as a biological marker for dozens of metals and toxic elements [...]

A recent study determined that bone area predicted the development of medial (inner side) and lateral (outer side) knee cartilage damage and loss of medial cartilage volume. Subchondral bone mineral density (BMD) was associated with medial defect development but not cartilage loss. Researchers believe subchondral bone changes and loss of cartilage contribute to the development [...]

6/23/2010 HEIDELBERG, Germany & LEXINGTON, Mass.–(BUSINESS WIRE)–febit today announced a restructuring as a consequence of its strategic focus on blood-based microRNA biomarker discovery, febit’s major business development in 2009/2010, and on partnerships and intellectual property (IP) commercialization. The new focus includes the collaboration and provision of high-end services for clinical researchers in academia, diagnostic companies [...]

A surprising discovery about the complex make-up of our cells could lead to the development of new types of medicines, a study suggests. Scientists studying interactions between cell proteins – which enable the cells in our bodies to function – have shown that proteins communicate not by a series of simple one-to-one communications, but by [...]

For three September days, Lisbon, Portugal will become the capital city of pharma quality professionals. Senior level executives from Europe and World leading companies will meet to discuss the best practices on how to achieve QC laboratory excellence, how and where to deploy and develop measurable quality systems, Quality Risk Management, QbD & PAT and [...]

“The AARP says that manufacturer prices for brand-name prescription drugs commonly used by people on Medicare rose 9.7% for the year ending in March – the biggest annual jump since the group started tracking prices in 2002,” The Wall Street Journal Health Blog reports. “The price of specialty drugs like biologics and injectables rose 9.2%. [...]

A team of scientists from Columbia University, Arizona State University, the University of Michigan, and the California Institute of Technology (Caltech) have programmed an autonomous molecular “robot” made out of DNA to start, move, turn, and stop while following a DNA track. The development could ultimately lead to molecular systems that might one day be [...]